QUIDEL CORPORATION (NASDAQ:QDEL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

QUIDEL CORPORATION (NASDAQ:QDEL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors of Certain Officers; Election of Directors’ Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

As indicated below, at the 2018 Annual Meeting of the Stockholders, the Company's Stockholders approved the Quidel Corporation 2018 Equity Incentive Plan.

Item 5.07Submission of Matters to a Vote of Security Holders.

On May15, 2018, Quidel Corporation (the “Company” or "Quidel") held its Annual Meeting of Stockholders at 8:30 a.m. local time at the San Diego Marriott Del Mar, 11966 El Camino Real, San Diego, California 92130. The following matters were voted upon at the meeting:

Proposal No.1

The Company’s stockholders elected eight individuals to the Board of Directors as set forth below:

Name

Votes For

Votes Withheld

Broker Non-Votes

Thomas D. Brown

31,947,752

272,072

3,551,067

Douglas C. Bryant

31,977,611

242,213

3,551,067

Kenneth F. Buechler

30,126,919

2,092,905

3,551,067

Mary Lake Polan

31,954,193

265,631

3,551,067

Jack W. Schuler

30,054,802

2,165,022

3,551,067

Charles P. Slacik

32,043,794

176,030

3,551,067

Matthew W. Strobeck

32,047,712

172,112

3,551,067

Kenneth J. Widder

29,718,383

2,501,441

3,551,067

Proposal No.2

The Company’s stockholders ratified the appointment of Ernst& Young LLP as the Company’s independent registered public accounting firm for the Company's 2018 fiscal year by the votes set forth in the table below:

Votes For

Votes Against

Abstentions

35,491,182

259,258

20,451

Proposal No.3

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers by the votes set forth in the table below:

Votes For

Votes Against

Abstentions

Broker Non-Votes

32,038,816

163,048

17,960

3,551,067

Proposal No.4

The Company’s stockholders approved the Quidel Corporation 2018 Equity Incentive Plan:

Votes For

Votes Against

Abstentions

Broker Non-Votes

29,584,079

2,619,800

15,945

3,551,067


About QUIDEL CORPORATION (NASDAQ:QDEL)

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The Company’s diagnostic testing solutions primarily include applications in infectious diseases, women’s health and gastrointestinal diseases. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers. It markets its products in the United States through a network of national and regional distributors and a direct sales force. Internationally, it sells and markets primarily through distributor arrangements. Its diagnostic solutions are used in the detection and diagnosis of many critical diseases and other medical conditions, including autoimmune diseases, bone health and thyroid diseases. It provides diagnostic testing solutions under various brand names, including Quidel, QuickVue+ and Thyretain.

An ad to help with our costs